Guillermo Lahera Forteza on Stroke and Mental Health
Guillermo Lahera Forteza, Professor of Psychiatry at the University of Alcalá, shared on LinkedIn:
”So there I am, in blue, surrounded by neurologists dressed in orange.
It was today at the II Carrera Popular del Día del Ictus, in Madrid.
It was a wonderful event and a meeting place for neurologists, nurses, rehabilitation specialists, neuropsychologists, patients, family members, managers, and many other people united in the fight against stroke.
And a psychiatrist?
Well, on this occasion, family reasons are important…
But it is also to highlight what often remains in the shadows: mental health after a cerebrovascular episode.
5 facts to remember:
- Post-stroke dementia: prevalence ≈ 27% and mortality 59% in prolonged follow-up (systematic review, Liu et al., 2023)
- Post-stroke aphasia: affects 20–30% of people after a stroke (Devereux et al., 2023)
- Risk of suicide: 73% higher in stroke survivors than in the general population (Skajaa et al., 2022)
- Post-stroke depression: approximately one-third of survivors experience it (Sexton et al., 2019)
- Dementia: affects 41% of men; cumulative dementia 20–30% at 5–15 years
This event — running together, “becoming visible” — is a powerful metaphor: the race to recovery does not end at the hospital door. Including mental health — from detection to treatment — is part of that journey.”
Stay updated with Hemostasis Today.
-
Oct 27, 2025, 12:12Maria Roussakis: It is an Honour to Be a Part of the ISBT Young Professionals Council
-
Oct 27, 2025, 05:47Ahmed Koriesh on The Novel Approach in Use of Tenecteplase
-
Oct 27, 2025, 04:42Louise Breslin: Exciting Results in The CRYPTICS Trial
-
Oct 26, 2025, 16:55ECTH 2025: 3 Unforgettable Days of Science and Shared Purpose
-
Oct 26, 2025, 16:35Ahmed Koriesh on Thrombolysis in Stroke Patients on DOACs
-
Oct 27, 2025, 13:00Hossam El Benawi Shares Multi Site LVT Study from Mayo Clinic
-
Oct 27, 2025, 08:01Acquired Hemophilia A (AHA) is Rare and Often Missed - RPTH Journal
-
Oct 27, 2025, 05:00Wolfgang Miesbach on WFH Guidelines Covering FDA/EMA-Approved AAV Gene Therapy for Hemophilia
-
Oct 26, 2025, 15:04Nita Radhakrishnan and Colleagues on Inherited Haematological Conditions
-
Oct 26, 2025, 14:55Anirban Sen Gupta on Biosynthetic Blood Surrogates Current State-of-Art
-
Oct 25, 2025, 07:42Adithya Hande: India’s Silent Killer and a Scientific Breakthrough
-
Oct 23, 2025, 09:57Arun V. J: Artificial Blood Is Closer Than You Think
-
Oct 23, 2025, 07:11Sebastien Lobet Presented the ACTIVLIM-Hemo Scale
-
Oct 23, 2025, 07:05Syed Ehsan Shah on Advantages of Werfen HemoCell Automation
-
Oct 22, 2025, 08:25Johanna Nystedt: Not Every Day We Can Release a New Blood Product to Meet An Unmet Medical Need!
-
Oct 27, 2025, 13:18Stroke Foundation Welcomes Jacqui McCallum as the New Executive Director
-
Oct 27, 2025, 12:54Guillermo Lahera Forteza on Stroke and Mental Health
-
Oct 27, 2025, 12:37Joshua Ngimbwa Recognised as the Best Male Junior Investigator Awardee at the Tanzania Health Summit
-
Oct 27, 2025, 08:00Rohit Gosain: Revumenib is Now FDA Approved for R/R AML with NPM1 Mutation
-
Oct 27, 2025, 06:30Andres Ricaurte Fajardo on CVT Experience from a Latin American Cohort